Cholesterol ester transfer protein (CETP) and atherosclerosis-Reference-Cited by-同舟云学术

Cholesterol ester transfer protein (CETP) and atherosclerosis

Published:2007-06 Issue:2 Volume:4 Page:137-145
ISSN:1740-6773
Container-title:Drug Discovery Today: Therapeutic Strategies
language:en
Short-container-title:Drug Discovery Today: Therapeutic Strategies

Author:

Polk Donna,Shah P.K.

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Reference84 articles.

1. Is relationship between serum cholesterol and risk for premature death from coronary heart disease continuous and graded: findings I 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT);Stamier;JAMA,1986

2. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators;Sacks;N. Engl. J. Med.,1996

3. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

4. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial;Lancet,2002

5. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial;Nissen;JAMA,2004

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Anacetrapib Inhibits the Activity of the Cholesteryl Ester Transfer Protein? Perspective through Atomistic Simulations;PLoS Computational Biology;2014-11-20

2. Lipid Exchange Mechanism of the Cholesteryl Ester Transfer Protein Clarified by Atomistic and Coarse-grained Simulations;PLoS Computational Biology;2012-01-12

3. Docking and molecular dynamics study on the inhibitory activity of N, N-disubstituted-trifluoro-3-amino-2-propanols-based inhibitors of cholesteryl ester transfer protein;Journal of Molecular Modeling;2010-11-06